MeSH D001064 - appendicitis
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| Amneal Pharmaceuticals | Meropenem | Meropenem | 2016-04-12 | |||
| B. Braun Medical | Meropenem | Meropenem | 2015-04-30 | |||
| Daewoong Pharmaceutical | Meropenem | Meropenem | 2015-12-18 | |||
| Eugia Pharma Specialties | Meropenem | Meropenem | 2017-03-27 | |||
| Gland Pharma | Meropenem | Meropenem | 2016-06-08 | |||
| Hospira | Meropenem | Meropenem | 2010-06-22 | |||
| HQ Specialty Pharma | Meropenem | Meropenem | 2019-08-16 | |||
| Menarini | Meropenem, Vaborbactam | Vaborem | 2018-11-20 | |||
| Pfizer | Meropenem | Merrem | 1996-06-21 | |||
| Qilu Pharmaceuticals | Meropenem | Meropenem | 2024-07-22 |
1
2
>
Clinical Trials
Historical Success Rate
Phase 1
67%4/6
Phase 2
26%6/23
Phase 3
67%6/9
Approved: 1Overall Success rate: 12%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use